Shareholders to Vote on 10M Share Equity Plan and Quorum-Assisting Preferred Stock

summarizeSummary

Cosmos Health is asking shareholders to approve a new equity incentive plan that could dilute existing shares by over 16% and a special class of preferred stock designed to ensure meeting quorums without affecting substantive votes, amidst ongoing financial distress.

check_boxKey Events · Financing and Capital Events · COSM

• Proposed 2026 Equity Incentive Plan

  Shareholders will vote on a new plan authorizing the issuance of up to 10,000,000 shares, representing a potential dilution of approximately 16.68% of the 59,956,994 shares outstanding as of May 19, 2026. This plan, if approved, could lead to significant dilution for existing shareholders.

• Quorum-Assisting Series B Preferred Stock

  A proposal to designate and issue 100,000 shares of Series B Preferred Stock, which would carry 100,000,000 votes exclusively for establishing a quorum at shareholder meetings. This stock is explicitly restricted from voting on any substantive matters, director elections, or transactions.

• Annual Meeting Proposals

  The preliminary proxy statement outlines proposals for the Annual Meeting on July 15, 2026, including the election of six directors and the ratification of the independent registered public accounting firm.

• Context of Financial Distress

  These proposals come after recent 10-K and 10-Q filings disclosed going concern warnings, significantly widened losses, increased cash burn, and material internal control weaknesses. The stock is also trading near its 52-week low.

auto_awesomeAnalysis · COSM · Trade & Services

Cosmos Health is seeking shareholder approval for a new 2026 equity incentive plan that could issue up to 10,000,000 shares, representing a potential dilution of approximately 16.68% of current outstanding shares. This substantial potential dilution is particularly notable given the company's recent disclosures of going concern warnings, widened losses, and increased cash burn. Additionally, the company proposes to designate and issue Series B Preferred Stock with 100,000,000 votes solely for establishing a quorum at shareholder meetings, explicitly without power to vote on substantive matters. This governance change aims to prevent meeting adjournments due to low retail shareholder participation, highlighting operational challenges in shareholder engagement.